PBE Among Technology ETFs
End-of-day Nov 20, 2026 · 23 Technology ETFs by 10Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.7% | −5.4% | −6.8% | −4.8% | +13.9% | +20.8% | +69.2% | +30.8% | +122.0% | +418.1% |
| Peer average | −5.6% | −11.2% | −14.8% | −18.1% | −5.7% | −2.0% | +47.3% | +12.2% | +330.1% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$59 of every $1,000 in PBE is Biogen
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | BIIBBiogen | Healthcare | 5.86% | $585.61 | 99K | $24.5M |
| 2 | GILDGilead Sciences | Healthcare | 5.86% | $585.56 | 147K | $24.5M |
| 3 | REGNRegeneron Pharmaceuticals | Healthcare | 5.79% | $579.40 | 26K | $24.2M |
| 4 | RPRXRoyalty Pharma | Healthcare | 5.71% | $570.72 | 352K | $23.8M |
| 5 | AMGNAmgen | Healthcare | 5.19% | $519.09 | 49K | $21.7M |
| 6 | VRTXVertex Pharmaceuticals | Healthcare | 4.93% | $492.62 | 40K | $20.6M |
| 7 | ILMNIllumina | Healthcare | 4.67% | $466.52 | 97K | $19.5M |
| 8 | NTRANatera | Healthcare | 4.50% | $450.43 | 65K | $18.8M |
| 9 | VCELVericel | Healthcare | 3.85% | $384.62 | 276K | $16.1M |
| 10 | MRNAModerna | Healthcare | 3.58% | $358.09 | 75K | $15.0M |
| 11 | TGTXTG Therapeutics | Healthcare | 3.34% | $334.04 | 215K | $14.0M |
| 12 | EXELExelixis | Healthcare | 3.31% | $331.17 | 210K | $13.8M |
| 13 | QGENQiagen | Healthcare | 3.24% | $324.42 | 273K | $13.6M |
| 14 | UTHRUnited Therapeutics | Healthcare | 3.08% | $307.67 | 23K | $12.9M |
| 15 | NBIXNeurocrine Biosciences | Healthcare | 2.91% | $291.31 | 78K | $12.2M |
of the $341B in 58 Technology ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | BIIB | Biogen | 5.86% |
| 2 | GILD | Gilead Sciences | 5.86% |
| 3 | REGN | Regeneron Pharmaceuticals | 5.79% |
| 4 | RPRX | Royalty Pharma | 5.71% |
| 5 | AMGN | Amgen | 5.19% |
| 6 | VRTX | Vertex Pharmaceuticals | 4.93% |
| 7 | ILMN | Illumina | 4.67% |
| 8 | NTRA | Natera | 4.50% |
| 9 | VCEL | Vericel | 3.85% |
| 10 | MRNA | Moderna | 3.58% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 25, 2026 | $0.0187 |
| Jun 22, 2026 | Jun 26, 2026 | $0.81 |
| Mar 23, 2026 | Mar 27, 2026 | $0.0824 |
| Dec 22, 2025 | Dec 26, 2025 | $0.42 |
| Sep 22, 2025 | Sep 26, 2025 | $0.23 |
| Jun 23, 2025 | Jun 27, 2025 | $0.13 |
| Mar 24, 2025 | Mar 28, 2025 | $0.0341 |
| Jun 24, 2024 | Jun 28, 2024 | $0.0082 |
| Mar 18, 2024 | Mar 22, 2024 | $0.0242 |
| Jun 20, 2023 | Jun 23, 2023 | $0.0141 |
| Mar 23, 2020 | Mar 31, 2020 | $0.0290 |
| Sep 24, 2018 | Sep 28, 2018 | $0.0021 |